Breakthrough Therapies - ALK with Dr. Ignatius Ou

Episode
62
Soundcloud
Share

In this episode of Lung Cancer Considered, Dr. Sai-Hong Ignatius Ou shares his career growth and experience participating and leading breakthrough clinical trials on therapies to treat ALK positive patients with lung cancer. Dr. Ou discusses a pivotal moment at the beginning of his career when he visited the Pfizer campus in California to learn about their effort to develop a phase 1 trial examining MET amplifications and MET mutations. The visit helped spur him to become more involved in lung cancer research.

Guest
Headshot of Dr. Ou
Sai-Hong Ignatius Ou

MD, PhD

Health Science Clinical Professor
Chao Family Comprehensive Cancer Center, Dept of Internal Medicine, Division of Hematology-Oncology, University of California Irvine School of Medicine, Orange, California.
Narjust Duma
Dr. Narjust Duma

MD

Assistant Professor of Medicine, Thoracic Oncologist
University of Wisconsin

Other Podcast

Dr. Eddie Garon
Episode
65
Tumor Board Discussion: Mesothelioma
Episode
63
ELCC Podcast
Episode
61